Einträge von Vogelhuber, Martin auf dem Publikationsserver

Harrer, Dennis Christoph , Herrmann, Markus, Vogelhuber, Martin, Geis, Sebastian, Mahr, Daniel, Niethard, Maya, Keil, Felix , Napodano, Gerardo, Herr, Wolfgang und Grube, Matthias (2025) Case Report: Nirogacestat therapy induces rapid response in a patient with refractory, life-threatening desmoid tumor. Frontiers in Oncology 15.

Araceli, Tommaso, Fischl, Anna, Haj, Amer, Doenitz, Christian, Stoerr, Eva-Maria, Hillberg, Andrea, Vogelhuber, Martin, Rosengarth, Katharina, Riemenschneider, Markus J. , Hau, Peter , Blazquez, Raquel, Pukrop, Tobias , Bumes, Elisabeth , Schmidt, Nils Ole und Proescholdt, Martin A. (2024) Psycho-oncological burden in patients with brain metastases undergoing neurological surgery. Frontiers in Oncology 14.

Fischl, Anna, Gerken, Michael, Lindberg-Scharf, Patricia , Haedenkamp, Tareq M. , Rosengarth, Katharina, Hillberg, Andrea, Vogelhuber, Martin, Schön, Ingrid, Proescholdt, Martin A. , Araceli, Tommaso, Koller, Michael , Herrmann, Anne , Kölbl, Oliver, Pukrop, Tobias , Riemenschneider, Markus J. , Schmidt, Nils Ole , Klinkhammer-Schalke, Monika, Linker, Ralf A., Hau, Peter und Bumes, Elisabeth (2024) Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their Caregivers. Current Oncology 31 (10), S. 6155-6170.

Reuthner, Kathrin, Aubele, P., Menhart, Karin , Rath, Philipp, Harrer, D. C., Herr, Wolfgang, Hahn, Joachim, Vogelhuber, Martin, Heudobler, Daniel , Lueke, F., Reichle, Albrecht und Grube, Matthias (2024) Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin’s disease developing resistance to pembrolizumab. Frontiers in Pharmacology 15.

Fante, Matthias A., Harrer, Dennis C., Zartner, Barbara, Lüke, Florian, Mayer, Stephanie, Menhart, Karin, Reichle, Albrecht , Herr, Wolfgang, Vogelhuber, Martin und Heudobler, Daniel (2023) All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma. Frontiers in Oncology 13.

Fischl, Anna, Gerken, Michael, Roos, PhilipP, Haedenkamp, Tareq M. , Hillberg, Andrea, Klinkhammer-Schalke, Monika, Kölbl, Oliver, Linker, Ralf A., Proescholdt, Martin A. , Pukrop, Tobias , Riemenschneider, Markus J. , Schmidt, Nils Ole , Schön, Ingrid, Vogelhuber, Martin, Hau, Peter und Bumes, Elisabeth (2023) Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study. Neuro-Oncology Practice 10 (5), S. 446-453.

Heudobler, Daniel, Fante, Matthias A., Felsensteiner, Mona, Mayer, Stephanie, Gerken, Michael, Klinkhammer-Schalke, Monika, Herr, Wolfgang, Vogelhuber, Martin und Reichle, Albrecht (2022) All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma. Frontiers in Oncology 2022 (12), S. 1-11.

Harrer, Dennis C., Jakob, Marcus, Vogelhuber, Martin, Lüke, Florian, Utpatel, Kirsten, Corbacioglu, Selim, Herr, Wolfgang, Reichle, Albrecht und Heudobler, Daniel (2022) Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis. Leukemia & Lymphoma 63 (12), S. 2858-2868. Volltext nicht vorhanden.

Harrer, Dennis Christoph, Buschauer, Sebastian, Sterz, Ulrich, Menhart, Karin, Wendl, Christina, Heudobler, Daniel, Grube, Matthias, Pukrop, Tobias , Herr, Wolfgang und Vogelhuber, Martin (2021) Gemcitabine Maintenance Therapy in Patients With Metastasized Soft Tissue Sarcomas. Frontiers in Oncology 2021 (11), S. 1-7.

Sterz, Ulrich, Grube, Matthias, Herr, Wolfgang, Menhart, Karin, Wendl, Christina und Vogelhuber, Martin (2021) Case Report: Dual Checkpoint Inhibition in Advanced Metastatic Osteosarcoma Results in Remission of All Tumor Manifestations—A Report of a Stunning Success in a 37-Year-Old Patient. Frontiers in Oncology 11 (684733), S. 1-7.

Lüke, Florian, Harrer, Dennis C., Menhart, Karin, Wolff, Daniel, Holler, Ernst, Hellwig, Dirk, Herr, Wolfgang, Grube, Matthias, Vogelhuber, Martin, Reichle, Albrecht und Heudobler, Daniel (2021) Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease. Frontiers in Pharmacology 12 (599561), S. 1-8.

Heudobler, Daniel, Schulz, Christian , Fischer, Jürgen R., Staib, Peter, Wehler, Thomas, Südhoff, Thomas, Schichtl, Thomas, Wilke, Jochen, Hahn, Joachim, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias , Herr, Wolfgang, Held, Swantje, Beckers, Kristine, Bouche, Gauthier und Reichle, Albrecht (2021) A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung). Frontiers in Pharmacology 12 (599598), S. 1-10.

Harrer, Dennis Christoph, Menhart, Karin, Mayer, Stephanie, Herr, Wolfgang, Reichle, Albrecht und Vogelhuber, Martin (2020) Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report. Frontiers in Oncology 10 (585830), S. 1-4.

Munker, Stefan, Vogelhuber, Martin, Bornschein, Jan, Stroszczynski, Christian, Evert, Matthias, Schlitt, Hans, Herr, Wolfgang und Teufel, Andreas (2020) EpiCO (epirubicin, cyclophosphamide and vincristine) as treatment for extrapulmonary high-grade neuroendocrine neoplasms. Zeitschrift für Gastroenterologie 58 (02), S. 133-136. Volltext nicht vorhanden.

Heudobler, Daniel, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias , Herr, Wolfgang, Gerner, Christopher , Pantziarka, Pan, Ghibelli, Lina und Reichle, Albrecht (2019) Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction. Frontiers in Oncology 9 (1408), S. 1-22.

Böll, Boris, Plütschow, Annette, Bürkle, Carolin, Atta, Johannes, Pfreundschuh, Michael, Feuring‐Buske, Michaela, Vogelhuber, Martin, Sökler, Martin, Eichenauer, Dennis A., Thielen, Indra, Tresckow, Bastian, Fuchs, Michael, Engert, Andreas und Borchmann, Peter (2019) Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group ( GHSG ) phase‐I trial. British Journal of Haematology 185 (1), S. 42-52. Volltext nicht vorhanden.

Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schäfer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josée M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Dührsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter und Engert, Andreas (2019) Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. Journal of Clinical Oncology 37 (31), S. 2835-2845. Volltext nicht vorhanden.

Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Thomas, Simone, Pukrop, Tobias, Hackl, Christina, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher und Reichle, Albrecht (2018) Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis. Frontiers in Pharmacology 9 (1357), S. 1-26.

Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Pukrop, Tobias, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher und Reichle, Albrecht (2018) Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue. International Journal of Molecular Sciences 19 (11), S. 3540.

Munker, Stefan, Gerken, Michael, Fest, Petra, Ott, Claudia, Schnoy, Elisabeth, Fichtner-Feigl, Stefan, Wiggermann, Philipp, Vogelhuber, Martin, Herr, Wolfgang, Stroszczynski, Christian, Schlitt, Hans Jürgen, Evert, Matthias, Reng, Michael, Klinkhammer-Schalke, Monika und Teufel, Andreas (2018) Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects. BMC Cancer 18 (455), S. 1-9.

Ott, Claudia, Gerken, Michael, Hirsch, Daniela , Fest, Petra, Fichtner-Feigl, Stefan, Munker, Stefan, Schnoy, Elisabeth, Stroszczynski, Christian, Vogelhuber, Martin, Herr, Wolfgang, Evert, Matthias, Reng, Michael, Schlitt, Hans Jürgen, Klinkhammer-Schalke, Monika und Teufel, Andreas (2018) Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Digestion 98 (3), S. 143-152. Volltext nicht vorhanden.

Osin, Rinat, Pankrath, Anna-Luise, Niederwieser, Dietger, Döhner, Hartmut, Hönig, Klaus, Vogelhuber, Martin, Mehnert, Anja , Weißflog, Gregor und Ernst, Jochen (2018) Dyadisches Coping von hämatoonkologischen Patienten und ihren Partnern: Übereinstimmungsmaße und Zusammenhänge mit sozialer Unterstützung und psychischer Belastung. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie 68 (02), S. 55-65. Volltext nicht vorhanden.

Schelker, Roland Christian, Herr, Wolfgang, Reichle, Albrecht und Vogelhuber, Martin (2018) Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience. BMC Cancer 18 (1). Volltext nicht vorhanden.

Weißflog, Gregor, Hönig, Klaus, Gündel, Harald, Lang, Dirk, Niederwieser, Dietger, Döhner, Hartmut, Vogelhuber, Martin, Mehnert, Anja und Ernst, Jochen (2017) Associations between dyadic coping and supportive care needs: findings from a study with hematologic cancer patients and their partners. Supportive Care in Cancer 25 (5), S. 1445-1454. Volltext nicht vorhanden.

Hierl, Marina, Pfirstinger, Jochen, Andreesen, Reinhard, Holler, Ernst, Mayer, Stephanie, Wolff, Daniel und Vogelhuber, Martin (2017) Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients. Oncology 93 (3), S. 157-163. Volltext nicht vorhanden.

Ernst, Jochen, Hinz, Andreas, Niederwieser, Dietger, Döhner, Hartmut, Hönig, Klaus, Vogelhuber, Martin, Mehnert, Anja und Weissflog, Gregor (2017) Dyadic coping of patients with hematologic malignancies and their partners and its relation to quality of life – a longitudinal study. Leukemia & Lymphoma 58 (3), S. 655-665. Volltext nicht vorhanden.

Behringer, Karolin, Goergen, Helen, Hitz, Felicitas, Zijlstra, Josée M, Greil, Richard , Markova, Jana, Sasse, Stephanie, Fuchs, Michael, Topp, Max S, Soekler, Martin, Mathas, Stephan, Meissner, Julia, Wilhelm, Martin, Koch, Peter, Lindemann, Hans-Walter, Schalk, Enrico, Semrau, Robert, Kriz, Jan, Vieler, Tom, Bentz, Martin, Lange, Elisabeth, Mahlberg, Rolf, Hassler, Andre, Vogelhuber, Martin, Hahn, Dennis, Mezger, Jörg, Krause, Stefan W , Skoetz, Nicole, Böll, Boris, von Tresckow, Bastian, Diehl, Volker, Hallek, Michael, Borchmann, Peter, Stein, Harald, Eich, Hans und Engert, Andreas (2015) Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. The Lancet 385 (9976), S. 1418-1427. Volltext nicht vorhanden.

Pfirstinger, Jochen, Kattner, Daniel, Edinger, Matthias , Andreesen, Reinhard und Vogelhuber, Martin (2014) The Impact of a Tumor Diagnosis on Patients' Attitudes toward Advance Directives. Oncology 87, S. 246-256.

Engert, Andreas, Josting, Andreas, Haverkamp, Heinz, Villalobos, Matthias, Lohri, Andreas, Sökler, Martin, Zijlstra, Josée, Sturm, Isrid, Topp, Max S., Rank, Andreas, Zenz, Thorsten, Vogelhuber, Martin, Nogova, Lucia, Borchmann, Peter, Fuchs, Michael, Flechtner, Hans-Henning und Diehl, Volker (2010) Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial. Journal of Clinical Oncology 28 (13), S. 2239-2245. Volltext nicht vorhanden.

von Landenberg, Philipp, Schölmerich, Jürgen, Andreesen, Reinhard, Vogelhuber, Martin und Lackner, Karl J. (2002) A case of Waldenstroem's disease with a monoclonal IgM antiphospholipid antibody. Rheumatology international 22 (3), S. 129-31. Volltext nicht vorhanden.